ReviewJournal of virology2025
Mammalian innate antiviral defenses: beyond interferon.
Review in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Discovering host-viral protein interactions in autophagy: A LIR discovery pipeline for identifying LC3-interacting region motifs in highly virulent viruses.PLoS pathogens · 2026Article
- IRES Mutation Confers a Replicative Advantage to SVA by Enhancing Translation Efficiency.Transboundary and emerging diseases · 2026Article
- Molecular signaling in coinfection: howFrontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Mammalian cells employ a wide array of antiviral defense mechanisms to restrict viral replication at virtually all steps of the viral life cycle. Notably, the interferon (IFN) response has been shown to play a central role in restricting the replication of disparate viral pathogens in mammals. Consequently, since its discovery in 1957, the IFN response has dominated antiviral immunity research, leaving IFN-independent pathways relatively understudied. Exploring these alternative host defenses is crucial for understanding the complete arsenal that mammalian hosts deploy to combat viral disease, as IFN responses undoubtedly work in concert with other antiviral defenses to achieve virus restriction. Here, we discuss selected examples of antiviral factors and pathways in mammals that are not classically associated with the IFN response. These defenses range from constitutively expressed host restriction factors that directly inhibit specific steps of the viral life cycle to signaling pathways that invoke IFN-independent antiviral gene expression programs to cell death mechanisms that sacrifice the infected cell to prevent viral spread. Ultimately, our goal is to highlight the diversity of IFN-independent antiviral defenses that mammalian hosts utilize to block viral infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.